Give AI agents structured email access with complete audit trails and human-gated review — built for the compliance demands of clinical research, regulatory affairs, and quality operations.
Biotech and life sciences organizations operate under some of the most demanding communication compliance requirements of any industry. FDA 21 CFR Part 11 mandates audit trails for electronic records. HIPAA restricts how patient and trial participant information can be transmitted. GxP principles require quality-relevant communications to be documented and version-controlled. ICH-GCP guidelines govern how clinical trial correspondence is conducted and preserved.
AI agents can meaningfully reduce coordination overhead in research operations — routing regulatory submission updates, notifying quality teams of audit findings, tracking supply chain events, summarizing trial status across sites. But any agent touching scientific, clinical, or safety-relevant email must operate under strict human oversight. A misrouted adverse event notification or an unsanctioned claim in an outbound message creates regulatory exposure that no automation benefit justifies.
MultiMail's `gated_all` oversight mode is the recommended configuration for regulated biotech workflows. Every outbound action — send, reply, or tag — requires explicit human approval before execution. The complete decision record is stored and queryable, satisfying audit trail requirements for supervised AI-assisted workflows.
FDA 21 CFR Part 11 and GxP frameworks require that regulated electronic communications maintain complete, tamper-evident audit records. Standard email systems provide no structured access log, making it difficult to demonstrate what an agent sent, when, and under whose authorization.
Emails referencing clinical trial participants or patient records must comply with HIPAA's minimum necessary standard and GDPR's data minimization principle. Agents processing inbound email must not cache, log, or forward PHI beyond what the specific workflow requires.
Serious adverse events require expedited reporting under ICH-GCP and FDA regulations — 7 days for fatal or life-threatening events, 15 days for other serious unexpected events. Agents coordinating safety communications must not delay or silently reroute escalation chains.
Emails related to IND, NDA, and BLA submissions, CRO coordination, and regulatory authority correspondence must be version-controlled and retrievable on demand. Agents that send submission-related communications without a documented approval chain create compliance gaps.
External communications about research findings or product capabilities must be reviewed for accuracy before transmission. FDA promotional regulations apply to outbound scientific claims even in B2B and CRO contexts, and agents cannot be trusted to self-certify accuracy.
Configure AI agents with `gated_all` oversight on mailboxes handling clinical trial coordination, regulatory submissions, and safety notifications. Every proposed send is queued for human review via `list_pending` and `decide_email` before any message leaves your organization. The approval decision, timestamp, and reviewer identity are recorded with the message.
Grant agents `read_only` access to regulated mailboxes for monitoring, summarization, and triage — without any ability to send or modify messages. Use `check_inbox` and `read_email` to build audit dashboards, detect unanswered adverse event reports, or flag overdue regulatory responses without exposing send capability.
For lower-risk internal workflows — supply chain updates, lab scheduling, internal status reports — `monitored` mode allows agents to act without pre-approval while notifying designated staff of every action taken. This keeps research teams moving without creating approval bottlenecks on non-regulated communications.
External research collaboration emails — partner updates, CRO coordination, academic correspondence — benefit from `gated_send`: agents read and organize autonomously, but all outbound messages require human approval. This balances operational efficiency with the accuracy and compliance review that external scientific communications require.
Pick your platform, copy the prompt, and paste it to your AI agent — it sets up MultiMail and builds the whole flow. Nothing to fill in.
| Regulation | Requirement | How MultiMail helps |
|---|---|---|
| FDA 21 CFR Part 11 | Electronic records used in regulated workflows must include audit trails showing who created, modified, or approved each record, with timestamps and signer identity for any electronic signature. | MultiMail records every agent action — draft, approval request, human decision, and final send — with timestamps and actor identity. The `decide_email` response includes `reviewer_id`, `decided_at`, and `notes`, providing a structured audit record for each regulated communication. Metadata fields allow attaching protocol IDs, workflow identifiers, and version references directly to messages. |
| HIPAA | Protected health information transmitted via email must be handled under the minimum necessary standard. Systems processing PHI must implement appropriate technical safeguards including access controls and encryption in transit. | MultiMail's `read_only` oversight mode allows agents to monitor and flag emails containing PHI without enabling any agent-initiated transmission. All API traffic is TLS-encrypted in transit. Agent access can be scoped to specific mailboxes, limiting PHI exposure to only the workflows that require it. A BAA is available for covered entity relationships. |
| GxP | Good Practice guidelines require that quality-relevant communications in manufacturing, laboratory, and clinical settings be documented, traceable, and controlled through defined approval processes. | `gated_all` oversight creates a mandatory approval checkpoint for every outbound message, ensuring quality communications pass through a human review step before transmission. Message metadata fields support attaching batch numbers, protocol identifiers, and quality event IDs for downstream traceability in your EDMS or LIMS. |
| ICH-GCP | Clinical trial communications must be documented to demonstrate that the trial was conducted in accordance with the approved protocol and that data integrity was maintained throughout. Sponsors and investigators must retain correspondence records. | MultiMail's `get_thread` and `check_inbox` endpoints give agents structured access to clinical communication history. Every agent action against a thread is logged with a timestamp and actor ID, supporting the documentation requirements ICH-GCP E6 imposes on sponsor and investigator communications. |
| GDPR | Personal data of EU data subjects — including clinical trial participants — must be processed lawfully, with purpose limitation, data minimization, and appropriate technical safeguards against unauthorized disclosure. | Agents operating in `read_only` or `gated_all` mode cannot exfiltrate data via unauthorized sends. Mailbox-level access scoping ensures agents only access data relevant to their specific workflow. API responses expose only the fields requested, supporting GDPR's data minimization principle for automated processing workflows. |
Email infrastructure built for AI agents. Verifiable identity, graduated oversight, and a hosted MCP server. Formally verified in Lean 4.